Genetic Analysis AS (FRA:8V8) Days Payable : 672.80 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Genetic Analysis AS Days Payable?

Genetic Analysis AS's average Accounts Payable for the three months ended in Mar. 2024 was €0.49 Mil. Genetic Analysis AS's Cost of Goods Sold for the three months ended in Mar. 2024 was €0.07 Mil. Hence, Genetic Analysis AS's Days Payable for the three months ended in Mar. 2024 was 672.80.

The historical rank and industry rank for Genetic Analysis AS's Days Payable or its related term are showing as below:

FRA:8V8' s Days Payable Range Over the Past 10 Years
Min: 188.62 Med: 420.15 Max: 591.06
Current: 291.18

During the past 5 years, Genetic Analysis AS's highest Days Payable was 591.06. The lowest was 188.62. And the median was 420.15.

FRA:8V8's Days Payable is ranked better than
85.29% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: 65.43 vs FRA:8V8: 291.18

Genetic Analysis AS's Days Payable increased from Mar. 2023 (391.84) to Mar. 2024 (672.80). It may suggest that Genetic Analysis AS delayed paying its suppliers.

Genetic Analysis AS Days Payable Historical Data

The historical data trend for Genetic Analysis AS's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Analysis AS Days Payable Chart

Genetic Analysis AS Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

188.87

476.01

582.26

331.33

438.95

Genetic Analysis AS Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial											391.84	531.08	146.16	180.54	672.80

Competitive Comparison of Genetic Analysis AS's Days Payable

For the Diagnostics & Research subindustry, Genetic Analysis AS's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetic Analysis AS's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Analysis AS's Days Payable distribution charts can be found below:

* The bar in red indicates where Genetic Analysis AS's Days Payable falls into.

Genetic Analysis AS Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Genetic Analysis AS's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.441	+	0.485)	/	2 )	/	0.385	*	365
=	0.463					/	0.385	*	365
=	438.95

Genetic Analysis AS's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (0.485	+	0.503)	/	2 )	/	0.067	*	365 / 4
=	0.494					/	0.067	*	365 / 4
=	672.80

Genetic Analysis AS Days Payable Related Terms

Thank you for viewing the detailed overview of Genetic Analysis AS's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Analysis AS (FRA:8V8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Analysis AS (FRA:8V8) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

GEAN:Sweden

Address

Kabelgata 8, Oslo, NOR, 0580

Website

https://www.genetic-analysis.com

Genetic Analysis AS is a research-driven diagnostic company dedicated to delivering innovative diagnostic solutions to the growing human microbiota market. It is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.

Genetic Analysis AS (FRA:8V8) Headlines

No Headlines